K. Michael Conaway sold Celgene Corporation (CELG) (CELG)
K. Michael Conaway (R-TX), a U.S. Representative, has disclosed 1 trade in Celgene Corporation (CELG) (CELG) since 2015, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: K. Michael Conaway sold $1,001 - $15,000 of Celgene Corporation (CELG) (CELG) on June 8, 2015. Since that trade, CELG is up +0.00% against the S&P 500 up +320.64%, an outperformance of -320.64%.
Data updated
K. Michael Conaway's CELG trades vs the price
CELG is up +0.00% since K. Michael Conaway sold on June 8, 2015, versus +320.64% for the S&P 500.
Performance since this trade
All K. Michael Conaway CELG trades
K. Michael Conaway & CELG trading FAQ
Is it legal for K. Michael Conaway to trade Celgene Corporation (CELG) (CELG) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Celgene Corporation (CELG) (CELG), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did K. Michael Conaway sell CELG?
K. Michael Conaway disclosed a sale of $1,001 - $15,000 of Celgene Corporation (CELG) (CELG) on June 8, 2015, according to public STOCK Act filings.
How has CELG performed since K. Michael Conaway's trade?
Since K. Michael Conaway sold CELG on June 8, 2015, the stock is up +0.00%, versus +320.64% for the S&P 500 over the same period, an outperformance of -320.64%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional CELG trades?
Quantellect tracks every disclosed congressional trade in Celgene Corporation (CELG) (CELG) on the Celgene Corporation (CELG) congressional trading page, which aggregates filings across all members of Congress.
K. Michael Conaway's CELG tradesAll congressional filings for Celgene Corporation (CELG)K. Michael Conaway's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.